LimFlow System's PROMISE II Pivotal Trial Results Published

March 30, 2023—LimFlow SA, a developer of minimally invasive technology for the treatment of chronic limb-threatening ischemia (CLTI), announced

Related Keywords

Cleveland , Ohio , United States , Tennessee , Nevada , Canada , Japan , Vanderbilt University , Mehdi Shishehbor , Daniel Clair , Las Vegas , University Hospitals , Vascular Institute , Foundation On , New England Journal , Late Breaking Clinical Trials , Coprincipal Investigators , Harrington Heart , Vascular Surgery , Vanderbilt University Medical Center Section , Surgical Sciences , Limflow Sa , Chronic Limb Threatening Ischemia , Ulti , Promise Ii , Transcatheter Arterialization Of Deep Veins , Adv , Viva22 , The New England Journal Of Medicine , Pivotal Trial , Limb Salvage , Ravenous ,